Home Newsfeeds Pioneer Bancorp Q2 EPS $0.25, Same YoY

Pioneer Bancorp Q2 EPS $0.25, Same YoY

Pioneer Bancorp (NASDAQ:PBFS) reported quarterly earnings of $0.25 per share. This is unchanged from the same period last year.

byHappy Mohamed

January 30, 2023

1 minute read

Pioneer Bancorp (NASDAQ:PBFS) reported quarterly earnings of $0.25 per share. This is unchanged from the same period last year.

Raymond James Downgrades Cheesecake Factory to Market Perform

By Benzinga Newsdesk

January 24, 8:18 AM

Raymond James analyst Brian Vaccaro downgrades Cheesecake Factory (NASDAQ:CAKE) from Outperform to Market Perform.

CAKE

Cohen & Steers Reported Preliminary Assets Under Management Of $87.3 Billion As Of January 31, 2023, An Increase Of $6.9 Billion From Assets Under Management At December 31, 2022

By Happy Mohamed

February 8, 5:54 PM

Cohen & Steers, Inc. (NYSE:CNS) today reported preliminary assets under management of $87.3 billion as of January 31, 2023, an increase of $6.9 billion from assets under management

CNS

Purple Biotech Reports New Preclinical Data On Potential Of NT219 To Re-sensitize Resistant Tumors To Immune Checkpoint Inhibitors

By Happy Mohamed

April 19, 8:23 AM

New preclinical data from study presented at the American Association for Cancer Research 2023 Annual Meeting, 18 April 2023 REHOVOT, Israel, April 19, 2023 (GLOBE NEWSWIRE)

PPBT

New Fortress Energy Announces Proposed Secondary Offering Of 6.9M Shares By Selling Stockholder

By Michael Horton

December 14, 5:49 PM

New Fortress Energy Inc. (NASDAQ:NFE) (the "Company") announced today the commencement of a proposed underwritten secondary public offering of 6,900,000 shares of the Company's common stock by Energy

NFE

Pioneer Bancorp Q2 EPS $0.25, Same YoY

Related Posts

Raymond James Downgrades Cheesecake Factory to Market Perform

Cohen & Steers Reported Preliminary Assets Under Management Of $87.3 Billion As Of January 31, 2023, An Increase Of $6.9 Billion From Assets Under Management At December 31, 2022

Purple Biotech Reports New Preclinical Data On Potential Of NT219 To Re-sensitize Resistant Tumors To Immune Checkpoint Inhibitors

New Fortress Energy Announces Proposed Secondary Offering Of 6.9M Shares By Selling Stockholder